Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Godfrey Grech

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Oncotarget|April 21, 2017
Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulationRosa Drago-Ferrante, Francesca Pentimalli, Daniela Carlisi, et al.
Nature Genetics|August 3, 2010
Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobinJoseph Borg, Petros Papadopoulos, Marianthi Georgitsi, et al.
Plos One|February 17, 2017
Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical PharmacogenomicsClint Mizzi, Eleni Dalabira, Judit Kumuthini, et al.
Plos One|September 17, 2016
A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical PharmacogenomicsClint Mizzi, Eleni Dalabira, Judit Kumuthini, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Oncotarget|April 21, 2017
Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulationRosa Drago-Ferrante, Francesca Pentimalli, Daniela Carlisi, et al.
Nature Genetics|August 3, 2010
Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobinJoseph Borg, Petros Papadopoulos, Marianthi Georgitsi, et al.
Plos One|February 17, 2017
Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical PharmacogenomicsClint Mizzi, Eleni Dalabira, Judit Kumuthini, et al.
Plos One|September 17, 2016
A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical PharmacogenomicsClint Mizzi, Eleni Dalabira, Judit Kumuthini, et al.
Pageof 4